See All Slides - tctmd.com

Slides

Presentation Cell Therapy 2012

Patient Access to Stem Cell Technology: The OKYANOS Heart Institute

Presenter: Matthew Feshbach

January 26, 2012

Presentation Cell Therapy 2012

Long-term Follow-up of Patients with AMI Treated with Adipose-Derived Stem Cells (APOLLO)

Presenter: Henricus J. Duckers

January 25, 2012

Presentation Cell Therapy 2012

IMPACT Clinical Trial Program: Findings and Strategic Update

Presenter: Timothy D. Henry

January 25, 2012

Presentation Cell Therapy 2012

Update on Standardization of CD133 Intramyocardial BMSC for Intramyocardial Delivery

Presenter: Gustav Steinhoff

January 25, 2012

Presentation Cell Therapy 2012

Periadventitial MAPC Administration in STEMI

Presenter: Marc S. Penn

January 25, 2012

Presentation

The Leipzig Prospective Vascular Ultrasound Registry in Radial Artery Catheterization

Presenter: M. Uhlemann

January 25, 2012

Presentation Cell Therapy 2012

JD200 for Heart Failure: Safety Study

Presenter: Amit Patel

January 25, 2012

Presentation Cell Therapy 2012

JD100 for Wound Healing: Safety Study

Presenter: Amit Patel

January 25, 2012

Presentation

Oclusión con Balón Proximal frente al Filtro de Protección Embólica en Pacientes Sometidos a Colocación de Stents en la Carótida (CAS)

Presenter: K. Bijuklic

January 25, 2012

Presentation Cell Therapy 2012

Platelet-Cell-therapy Clinical Strategy: BioParadox, Inc.

Presenter: Todd J. Brinton

January 25, 2012

Advertisement

Slides

Patient Access to Stem Cell Technology: The OKYANOS Heart Institute

Long-term Follow-up of Patients with AMI Treated with Adipose-Derived Stem Cells (APOLLO)

IMPACT Clinical Trial Program: Findings and Strategic Update

Update on Standardization of CD133 Intramyocardial BMSC for Intramyocardial Delivery

Periadventitial MAPC Administration in STEMI

The Leipzig Prospective Vascular Ultrasound Registry in Radial Artery Catheterization

JD200 for Heart Failure: Safety Study

JD100 for Wound Healing: Safety Study

Oclusión con Balón Proximal frente al Filtro de Protección Embólica en Pacientes Sometidos a Colocación de Stents en la Carótida (CAS)

Platelet-Cell-therapy Clinical Strategy: BioParadox, Inc.

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content